Clearance mechanisms of von Willebrand factor and factor VIII.
Lenting
P J
PJ
Department of Clinical Chemistry and Haematology, Laboratory for Thrombosis and Haemostasis, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. p.j.lenting@umcutrecht.nl
VAN Schooten
C J M
CJ
Denis
C V
CV
D000017:ABO Blood-Group System / Q000378:metabolism; D051722:ADAM Proteins / Q000097:blood; D000071120:ADAMTS13 Protein; D037263:Asialoglycoprotein Receptor / Q000097:blood; D001665:Binding Sites; D005169:Factor VIII / Q000378:metabolism*; D006031:Glycosylation; D019812:Heparan Sulfate Proteoglycans / Q000097:blood; D006801:Humans; D066298:In Vitro Techniques; D026503:Low Density Lipoprotein Receptor-Related Protein-1 / Q000097:blood; D008657:Metabolic Clearance Rate; D009154:Mutation; D011973:Receptors, LDL / Q000097:blood; D014841:von Willebrand Factor / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
D000017:ABO Blood-Group System; D037263:Asialoglycoprotein Receptor; D019812:Heparan Sulfate Proteoglycans; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D011973:Receptors, LDL; D014841:von Willebrand Factor; D005169:Factor VIII; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human